Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury.


Journal

Case reports in medicine
ISSN: 1687-9627
Titre abrégé: Case Rep Med
Pays: United States
ID NLM: 101512910

Informations de publication

Date de publication:
2021
Historique:
received: 24 03 2021
accepted: 04 05 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 29 5 2021
Statut: epublish

Résumé

Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduced kidney function, or faulty measurement techniques. We herein present a case of a young pregnant woman who presented with mild acute kidney injury (AKI), invasive mucormycosis receiving liposomal amphotericin, and hyperphosphatemia out of proportion to the degree of kidney injury. While the patient was given routine phosphate-binding agent by her primary care team for presumed AKI-associated hyperphosphatemia, a full investigation by the renal consulting team for contributing factors other than kidney injury revealed that she actually had pseudohyperphosphatemia associated with the use of liposomal amphotericin. Erroneous treatment of pseudohyperphosphatemia may have been detrimental to this pregnant patient. A literature review for conditions associated with pseudohyperphosphatemia other than the use of liposomal amphotericin will be discussed.

Identifiants

pubmed: 34046068
doi: 10.1155/2021/9962624
pmc: PMC8128612
doi:

Types de publication

Case Reports

Langues

eng

Pagination

9962624

Informations de copyright

Copyright © 2021 Phuong Chi Pham et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Am Soc Nephrol. 1995 Aug;6(2):154-64
pubmed: 7579079
Clin Biochem. 1995 Aug;28(4):391-3
pubmed: 8521592
Clin Chem. 1986 Aug;32(8):1537-9
pubmed: 3731447
Acta Med Scand. 1987;222(1):89-91
pubmed: 3115064
Pediatr Nephrol. 2006 Feb;21(2):301-2
pubmed: 16328539
Am J Nephrol. 2013;38(1):50-7
pubmed: 23817179
Ann Clin Biochem. 1994 May;31 ( Pt 3):249-54
pubmed: 8067665
Indian J Nephrol. 2014 Nov;24(6):409-10
pubmed: 25484545
Clin Chim Acta. 2008 Jan;387(1-2):145-9
pubmed: 17936740
Clin Chem. 1973 Apr;19(4):436-7
pubmed: 4704930
Arch Intern Med. 1985 Apr;145(4):743-4
pubmed: 3985738
Kidney Int. 1992 Sep;42(3):727-34
pubmed: 1405350
Cancer. 1991 Sep 1;68(5):1092-4
pubmed: 1913479
Am J Kidney Dis. 1988 Mar;11(3):260-3
pubmed: 3125742
Front Horm Res. 2019;51:147-159
pubmed: 30641531
Clin Chem Lab Med. 2004 Jan;42(1):107-8
pubmed: 15061391
Ann Clin Biochem. 1989 May;26 ( Pt 3):300-1
pubmed: 2764478
Obstet Gynecol. 2009 Dec;114(6):1326-1331
pubmed: 19935037

Auteurs

Phuong Chi Pham (PC)

Olive View-UCLA Medical Center, Division of Nephrology, Sylmar, CA, USA.

Raghu Konanur Ventakaram (R)

Olive View-UCLA Medical Center, Division of Nephrology, Sylmar, CA, USA.

Jimmy Pham (J)

Olive View-UCLA Medical Center, Division of Nephrology, Sylmar, CA, USA.

Harpreet Sidhu (H)

Olive View-UCLA Medical Center, Division of Nephrology, Sylmar, CA, USA.

Nada Bader (N)

Olive View-UCLA Medical Center, Division of Nephrology, Sylmar, CA, USA.

Phuong Mai Pham (PM)

Greater Los Angeles Veterans Administration, Sepulveda Ambulatory Care Center, Los Angeles, CA, USA.

Phuong Thu Pham (PT)

Ronald Reagan UCLA Medical Center, David Geffen School of Medicine, Kidney Transplant Program, Los Angeles, CA, USA.

Classifications MeSH